Coagulopathy, venous thromboembolism, and anticoagulation in patients with COVID‐19

PP Dobesh, TC Trujillo - Pharmacotherapy: The Journal of …, 2020 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has led to a worldwide
pandemic, and patients with the infection are referred to as having COVID‐19. Although …

[HTML][HTML] Pharmacological and clinical application of heparin progress: An essential drug for modern medicine

M Qiu, S Huang, C Luo, Z Wu, B Liang, H Huang… - Biomedicine & …, 2021 - Elsevier
Heparin is the earliest and most widely used anticoagulant and antithrombotic drug that is
still used in a variety of clinical indications. Since it was discovered in 1916, after more than …

Comparative effectiveness of direct oral anticoagulants and warfarin for the treatment of left ventricular thrombus

ME Bass, TH Kiser, RL Page, CK McIlvennan… - Journal of Thrombosis …, 2021 - Springer
Left ventricular (LV) thrombus is a complication of acute endomyocardial injury and chronic
ventricular wall hypokinesis, resulting in increased risk of thromboembolic complications …

Low molecular weight heparin versus unfractioned heparin for anticoagulation during perioperative extracorporeal membrane oxygenation: A single center …

J Gratz, A Pausch, E Schaden, A Baierl… - Artificial …, 2020 - Wiley Online Library
Extracorporeal membrane oxygenation (ECMO) is gaining importance in the perioperative
management of lung transplant patients. To date, the ideal substance for anticoagulation of …

[HTML][HTML] Editor's Choice–European Society for Vascular Surgery (ESVS) 2023 clinical practice guidelines on antithrombotic therapy for vascular diseases

CP Twine, SK Kakkos, V Aboyans… - European Journal of …, 2023 - Elsevier
1.1. Purpose The European Society for Vascular Surgery (ESVS) has developed a series of
clinical practice guidelines for clinicians caring for patients with vascular diseases. This is …

Acute pulmonary embolism in cancer patients admitted to intensive care unit: Impact of anticoagulant treatment on 90-day mortality and risk factors, results of a …

D Mokart, E Serre, F Bruneel, A Kouatchet… - Thrombosis …, 2024 - Elsevier
Background Acute pulmonary embolism (PE) is a life-threatening situation in cancer
patients. In this situation, anticoagulant therapy is complex to administer due to the risk of …

The Role of Injectables in the Treatment and Prevention of Cancer-Associated Thrombosis

M Napolitano, S Siragusa - Cancers, 2023 - mdpi.com
Simple Summary People with cancer are at an increased risk of developing blood clots. Both
cancer and anti-cancer treatment are responsible for this risk. In some types of cancer, such …

Impact of macrolide antibiotics on hospital readmissions and other clinically important outcomes in critically Ill patients with acute exacerbations of chronic obstructive …

TH Kiser, PM Reynolds, M Moss… - … : The Journal of …, 2019 - Wiley Online Library
Study Objective To assess whether a macrolide‐based antibiotic treatment strategy reduces
in‐hospital mortality, decreases hospital readmissions, or improves other clinically important …

危重症患者静脉血栓栓塞症风险预测模型的研究进展

张亚斌, 马丹, 李蕊, 司爱冰, 王水雨 - 中国护理管理, 2022 - zghlgl.com
危重症患者静脉血栓栓塞症风险预测模型的研究进展 Page 1 综述 Reviews 1116 Chinese
Nursing Management Vol.22, No.7, July 15, 2022 [ 摘要] 从ICU 患者静脉血栓栓塞症的危险因素 …

Heparin-Induced Thrombocytopenia (HIT) in the Direct Oral Anticoagulants (DOAC) Era

RC Mahoney, TG DeLoughery, E Jung… - Annals of Vascular …, 2024 - Elsevier
Background Heparin-induced thrombocytopenia (HIT) is an uncommon complication of
heparin therapy with significant risk for severe morbidity and mortality. We investigated the …